Real Estate
Sabra Health Care REIT, Inc.(SBRA)
Live Price
Offline$18.73
+1.30% today
1Y Change
+0.75%
Window
Jun 23, 2025 โ Jun 12, 2026
- Market Cap
- $5.13B
- Revenue Growth
- +10.2%
- EPS Growth
- +18.5%
- Dividend Yield
- 5.9%
Coverage: 245 bars ยท Jun 23, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sabra Health Care REIT, Inc. (SBRA) is a Real Estate stock with a market cap of $5.13B and listed on NASDAQ. The stock last traded around $18.73 and up 0.8% across the available one-year price window (Jun 23, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of +10.2%, EPS growth of +18.5%, a dividend yield of 5.9%. What stands out right now is revenue +10.2%, EPS +18.5%, free cash flow +12.3% with operating margin 29.0% and ROIC 34.3%. The dividend matters to the case here, with a current yield around 5.9%. Valuation already assumes a fairly strong business story at P/E 32.9 and price/sales 6.3. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines SBRA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Real Estate peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Near sector median
+10.2% vs +11.4% peer median
Operating Margin
Below sector median
+29.0% vs +59.6% peer median
P/E
Above sector median
32.9 vs 19.5 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on May 4, 2026, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +10.2% and EPS at +18.5%, with operating margin around 29.0%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 5.9%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +1.1% over the next 5 trading days and finished higher after 2 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 May 4, 2026 | โ | -0.4% | +1.1% | -9.2% |
2026 Feb 12, 2026 | +123.5% | -0.4% | -1.6% | +1.8% |
2025 Nov 5, 2025 | +0.0% | +3.6% | +3.7% | +4.7% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SBRA
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
SBRA Max Drawdown
-16.65%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for SBRA and SPY.
Company Overview
Sabra Health Care REIT, Inc.
NASDAQ Global Select
As of March 31, 2022, Sabra's investment portfolio included 416 real estate properties held for investment. This consists of (i) 279 Skilled Nursing/Transitional Care facilities, (ii) 59 Senior Housing communities (Senior Housing - Leased), (iii) 50 Senior Housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing - Managed), (iv) 13 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 16 investments in loans receivable (consisting of (i) two mortgage loans, (ii) one construction loan and (iii) 13 other loans), seven preferred equity investments and one investment in an unconsolidated joint venture. As of March 31, 2022, Sabra's real estate properties held for investment included 41,445 beds/units, spread across the United States and Canada.
- Leadership
- Richard K. Matros
- IPO Date
- Apr 2, 2002
- Employees
- 50
- Street Address
- 18500 Von Karman Avenue
- Mailing
- Irvine, CA, 92612
- Region
- Irvine, CA, US
- Reporting Currency
- USD
- Investor Line
- 888-393-8248
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 32.9
- EV/EBITDA
- 17.6
- Price/Sales
- 6.3
- Price/Book
- 1.8
Growth
- Revenue
- +10.2%
- EPS
- +18.5%
- Free Cash Flow
- +12.3%
Profitability
- Gross Margin
- 63.5%
- Operating Margin
- 29.0%
- Net Margin
- 19.2%
- ROE
- 5.6%
- ROIC
- 34.3%
Balance Sheet
- Debt/Equity
- 0.96
- Current Ratio
- 29.68
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.